Binding of a new multidrug resistance modulator, S9788, to human plasma proteins and erythrocytes
- 1 March 1995
- journal article
- research article
- Published by Springer Nature in Investigational New Drugs
- Vol. 13 (1) , 37-41
- https://doi.org/10.1007/bf02614218
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Reversal of multidrug resistance by a new lipophilic cationic molecule, S9788. Comparison with 11 other MDR-modulating agents in a model of doxorubicin-resistant rat glioblastoma cellsEuropean Journal Of Cancer, 1993
- Comparative binding of etretinate and acitretin to plasma proteins and erythrocytesBiochemical Pharmacology, 1992
- In vivo evidence of complete circumvention of vincristine resistance by a new triazinoaminopiperidine derivative S 9788 in P388/VCR leukemia modelCancer Chemotherapy and Pharmacology, 1992
- Binding of retelliptine, a new antitumoral agent, to serum proteins and erythrocytesBiochemical Pharmacology, 1990
- Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy.Proceedings of the National Academy of Sciences, 1990
- Binding of indapamide to serum proteins and erythrocytesBiochemical Pharmacology, 1988